ICCCI is pleased to announce it has connected companies that joined forces for the TAČR Delta 2 program. This July, Czech company Icontio, Ltd. and Israeli ATLASense Biomed Ltd. signed the Common Proposal of the TAČR Delta 2 project “Improving the quality of treatment after stroke: Development of a system for telemetry and integration into RES-Q to improve decision-making processes”. Within the Czech and Israeli cooperation, the companies are going to develop a system to improve the quality of information about patients after stroke.
Other Czech partners to Icontio, Ltd. in this international cooperation are: Health Management Institute, z.ú., Tomáš Bata University in Zlín and Palacký University in Olomouc. FNUSA, FNOL and KNTB will be involved in the testing. Prof. Robert Mikulík, M.D., Ph.D., Head of the Cerebrovascular Research Programme at the International Clinical Research Centre (FNUSA-ICRC), is the expert/medical guarantor of the project. In addition other partners in this international cooperation are companies from Taiwan.